RxPerts Academy

Knowledge for the Next Era of Healthcare

Blog Posts

Blog Post

This fall, I had the opportunity to participate in both state and national meetings where information was presented about evolving value-based payment models and the role pharmacists may play in improving quality metrics. In parti...

View Blog Post
Blog Post

After a steady rise, trends show a decline starting in 2011. There has been an epidemic of prescription opioid abuse over the last two decades. A 2015 New England Journal of Medicine study authored by drug abuse experts from mu...

View Blog Post
Blog Post

Prescribers and pharmacists nationwide have encountered enough frustrating drug shortages recently that it has simply become a way of life for clinicians. But it shouldn’t have to be. The keys to solving the drug shortage pr...

View Blog Post
Blog Post

The U.S. Food and Drug Administration (FDA) recently issued a revised Pregnancy Lactation Labeling Rule (PLLR) after 35 years of rating medication safety for pregnant and breast-feeding women with the traditional lettering scale: ...

View Blog Post
Blog Post

The Centers for Disease Control (CDC) announced that prescription drug abuse is the nation’s fastest growing drug problem. Here are the facts from CDC.gov that back up tha...

View Blog Post
Blog Post

Opportunities to provide medication therapy management (MTM) services continue to grow. As a pharmacist, are you ready to meet the demand? Ensuring continued competency to conduct comprehensive medication reviews and provide o...

View Blog Post
Blog Post

A recent study by Whiting, et al, (JAMA 2015) performed an extensive literature review using 28 databases and provided assessment of the indications, benefits and adverse effects of medical marijuana and cannabinoids. Using a r...

View Blog Post
Blog Post

Using nonsteroidal anti-inflammatory drugs (NSAIDs) such as ibuprofen after a heart attack can increase the risk of death, recurrent heart attack, stroke and bleeding in patients taking antithrombotic medications. A study publi...

View Blog Post
Blog Post

Dabigatran (Pradaxa) is a member of a group of new oral anticoagulants which include rivoraxaban (Xarelto), apixaban (Eliquis) and edoxaban (Savaysa). At the present time, there are no evidence-based guidelines for dental perip...

View Blog Post

Pages

Become an RxPerts Insider

Sign up to receive the latest news and information!

Sign Up